Epithelial Invasion by Escherichia coli Bearing Dr Fimbriae Is Controlled by Nitric Oxide-Regulated Expression of CD55

Infection and Immunity

Volumn 72, Issue 5, 2004, Pages 2907-2914

  Fang, Li ^a   Nowicki, Bogdan J ^a   Urvil, Petri ^a   Goluszko, Pawel ^a   Nowicki, Stella ^a   Young, Steven L ^b   Yallampalli, Chandrasekhar ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b University of Missouri   (United States)

^c Medical Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BINDING AFFINITY; CANCER CELL CULTURE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; EPITHELIUM CELL; ESCHERICHIA COLI; FIMBRIA; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANTIGENS, CD55; BASE SEQUENCE; CELL LINE; EPITHELIAL CELLS; ESCHERICHIA COLI; FIMBRIAE, BACTERIAL; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RNA, MESSENGER;

EID: 2142657871     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.5.2907-2914.2004     Document Type: Article

References (42)

1. Bredt, D. S., and S. H. Snyder. 1990. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87:682-685.
2. De Groote, M. A., and F. C. Fang. 1995. NO inhibitions: antimicrobial properties of nitric oxide. Clin. Infect. Dis. 21(Suppl. 2):S162-S165.
3. Dong, Y.-L., B. S. Dai, P. Singh, and C. Yallampalli. 1997. Involvement of nitric oxide pathway in prostaglandin F2α-induced preterm labor in rats. Am. J. Obstet. Gynecol. 177:907-918.
4. Dong, Y.-L., P. R. R. Gangula, and C. Yallampalli. 1996. Nitric oxide synthase isoforms in rat uterus: differential regulation during pregnancy and labor. J. Reprod. Fertil. 107:249-254.
5. Fang, F. C. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Investig. 99:2818-2825.
6. Fang, L., B. J. Nowicki, Y.-L. Dong, and C. Yallampalli. 1999. Localized increase in nitric oxide and the expression of nitric oxide synthase isoforms in rat uterus with experimental intra-uterine infection. Am. J. Obstet. Gynecol. 181:601-609.
7. Gangula, P. R. R., Y.-L. Dong, and C. Yallampalli. 1997. Rat myometrial smooth muscle cells express endothelial nitric oxide synthase. Hum. Reprod. 12:561-568.
8. Gibbs, R. S., R. Romero, S. L. Hillier, D. A. Eschenhach, and R. L. Sweet. 1992. A review of premature birth and subclinical infection. Am. J. Obstet. Gynecol. 166:1515-1528.
9. Goluszko, P., S. L. Moseley, L. D. Truong, A. Kaul, J. R. Williford, R. Selvarangan, S. Nowicki, and B. Nowicki. 1997. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. J. Clin. Investig. 99:1662-1672.
10. Goluszko, P., V. Popov, R. Selvarangan, S. Nowicki, T. Pham, and B. J. Nowicki. 1997. Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. J. Infect. Dis. 176:158-167.
11. Hara, T., M. Kojima, H. Fukuda, T. Masaoka, Y. Fukumori, and M. Matsumoto. 1992. Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies. Br. J. Haematol. 82:368-373.
12. Hart, A., B. J. Nowicki, B. Reisner, E. Pawelczyk, P. Goluszko, P. Urvil, G. D. Anderson, and S. Nowicki. 2001. Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin. J. Infect. Dis. 183:1526-1529.
13. Hart, A., T. Pham, S. Nowicki, E. B. Whorton, Jr., M. G. Martens, G. D. Anderson, and B. J. Nowicki. 1996. Gestational pyelonephritis-associated Escherichia coli isolates represent a nonrandom, closely related population. Am. J. Obstet. Gynecol. 174:983-989.
14. Hirsch, E., I. Saotome, and D. Hirsh. 1995. A model of intrauterine infection and preterm delivery in mice. Am. J. Obstet. Gynecol. 172:1598-1603.
15. Hourcade, D., M. K. Liszewski, M. Krych-Goldberg, and J. P. Atkinson. 2000. Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1. Immunopharmacology 49:103-116.
16. Hsu, C. D., E. Meaddough, K. Aversa, S. F. Hong, I. S. Lee, R. O. Bahodo-Singh, L. C. Lu, and J. A. Copel. 1998. Dual roles of amniotic fluid nitric oxide and prostaglandin E2 in preterm labor with intra-amniotic infection. Am. J. Physio. Heart Circ. Physiol. 15:683-687.
17. Hyc, A., A. Osiecka-Iwan, R. Strzelczyk, and S. Moskalewski. 2003. Effect of IL-1β, TNF-α, and IL-4 on complement regulatory protein mRNA expression in human articular chondrocytes. Int. J. Mol. Med. 11:91-94.
18. Inoue, H., M. Mizuno, T. Uesu, and T. Tsuji. 1994. Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer. Acta Med. Okayama 48:271-277.
19. Johnson, J. R., K. M. Skubitz, B. J. Nowicki, K. Jacques-Palaz, and R. M. Rakita. 1995. Nonlethal adherence to human neutrophils mediated by Dr antigen-specific adhesins of Escherichia coli. Infect. Immun. 63:309-316.
20. Kaul, A., M. Nagamani, and B. Nowicki. 1995. Decreased expression of endometrial decay accelerating factor (DAF), a complement regulatory protein, in patients with luteal phase defect. Am. J. Reprod. Immunol. 34:236-240.
21. Kaul, A., B. J. Nowicki, M. G. Martens, P. Goluszko, A. Hart, M. Nagamani, T. Q. Pham, and S. Nowicki. 1994. Decay-accelerating factor is expressed in the human endometrium and may serve as the attachment ligand for Dr pili of Escherichia coli. Am. J. Reprod. Immunol. 32:194-199.
22. Kaul, A. K., D. Kumar, M. Nagamani, P. Goluszko, S. Nowicki, and B. J. Nowicki. 1996. Rapid cyclic changes in density and accessibility of endometrial ligands for Escherichia coli Dr fimbriae. Infect. Immun. 64:611-515.
23. Krohn, M. A., S. L. Hillier, R. P. Nugent, M. F. Cotch, J. C. Carey, R. S. Gibbs, D. A. Eschenbach, et al. 1995. The genital flora of women with intraamniotic infection. J. Infect. Dis. 171:1475-1480.
24. Lublin, D. M., and J. P. Atkinson. 1989. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7:35-58.
25. Lublin, D. M., and K. E. Coyne. 1991. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage. J. Exp. Med. 174:35-44.
26. Medof, M. E., D. M. Lublin, V. M. Holers, D. J. Ayers, R. R. Getty, J. F. Leykam, J. P. Atkinson, and M. L. Tykocinski. 1987. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc. Natl. Acad. Sci. USA 84:2007-2011.
27. Nathan, C., and Q. W. Xie. 1994. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:13725-13728.
28. Natuzzi, E. S., P. C. Ursell, M. Harrison, C. Buscher, and R. K. Riemer. 1993. Nitric oxide synthase activity in the pregnant uterus decreases at parturition. Biochem. Res. Commun. 194:1-8.
29. Nishida, M., K. Kasahara, M. Kaneko, and H. Iwasaki. 1985. Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obst. Gynecol. Jpn. 37: I103-I111.
30. Nowicki, B., L. Fang, J. Singhal, and C. Yallampalli. 1997. Lethal outcome of uterine infection in pregnant but not in nonpregnant rats and increased rat death with inhibition of nitric oxide. Am. J. Reprod. Immunol. 38:309-312.
31. Nowicki, B., A. Hart, K. E. Coyne, D. M. Lublin, and S. Nowicki. 1993. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction. J. Exp. Med. 178:2115-2121.
32. Nowicki, B., S. Nowicki, and R. Selvarangan. 2001. Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. J. Infect. Dis. 183:S24-S27.
33. Nowicki, B. J., J. Singhal, L. Fang, S. Nowicki, and C. Yallampalli. 1999. Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/Hej mice. Infect. Immun. 67:2421-2427.
34. Nowicki, S., B. Nowicki, T. Pham, R. Hasan, and M. Nagamani. 2001. Expression of decay accelerating factor in endometrial adenocarcinoma is inversely related to that stage of tumor. Am. J. Reprod. Immunol. 46:144-148.
35. Schuurman, H. J., G. Pino-Chavez, M. J. Phillips, L. Thomas, D. J. White, and E. Cozzi. 2002. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors. Transplantation 73:1146-1151.
36. Selvarangan, R., P. Goluszko, V. Popov, J. Singhal, T. Pham, D. M. Lublin, S. Nowicki, and B. Nowicki. 2000. Role of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coli. Infect. Immun. 68:1391-1399.
37. Tschudi, M. R., M. Barton, N. A. Bersinger, P. Moreau, F. G. Cosentino, G. Nell, T. Malinski, and T. F. Luscher. 1996. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J. Clin. Investig. 98:899-905.
38. Tschugguel, W., C. Schneeberger, G. Unfried, K. Czerwenka, W. Weninger, M. Mildner, J. R. Bishop, and J. Huber. 1998. Induction of inducible nitric oxide synthase expression in human secretory endometrium. Hum. Reprod. 13:436-444.
39. Xu, C., D. Mao, V. M. Holers, B. Palanca, A. M. Cheng, and H. Molina. 2000. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287:498-501.
40. Yallampalli, C., Y. L. Dong, P. R. R. Gangula, and L. Fang. 1998. Role and regulation of nitric oxide in the uterus during pregnancy and parturition. J. Soc. Gynecol. Investig. 5:58-67.
41. Yallampalli, C., H. Izumi, M. Byam-Smith, and R. E. Garfield. 1994. An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am. J. Obstet. Gynecol. 170:175-185.
42. Young, S. L., B. A. Lessey, M. A. Fritz, W. R. Meyer. M. J. Murray, P. L. Speckman, and B. J. Nowicki. 2002. In vivo and in vitro evidence suggest that HB-EGF regulates endometrial expression of human decay-accelerating factor. J. Clin. Endocrinol. Metab. 87:1368-1375.